Clinical Trial Update: Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating an oral-switch strategy during treatment of left-sided infective endocarditis caused by multi-susceptible Staphylococcus has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infective Endocarditis

Snippet

Sponsor: University Hospital, Tours | Conditions: Infective Endocarditis | Phase 3 | Status: COMPLETED